Sung-Jin Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sung-Jin Kim has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Do-Un Jung
Department of Psychiatry, Busan Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea
5 shared publications - Jung-Joon Moon
Department of Psychiatry, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
5 shared publications - Dong-Wook Jeon
Department of Psychiatry, Busan Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea
3 shared publications - Yeon-Sue Kim
Department of Psychiatry, Pusan National University Yangsan Hospital, 50612 Yangsan, Republic of Korea
2 shared publications - Dong Jin Shin
Department of Psychiatry, Busan Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea
1 shared publication - Jae-Hoon Jeong
인제대학교 의과대학 부산백병원 정신건강의학교
1 shared publication
Latest Publications
- 30 May 2025
- Published by Taylor & Francis in Psychiatry
- Vol. 89 (1) , 69-81
Relationship Between Cognitive and Daily Living Functions and Insight in Patients with Schizophrenia
To investigate the relationships between insight, cognition, and daily living functions in patients with schizophrenia. Fifty-six clinically stable patients with schizophrenia were evaluated for clinical symptoms using the Positive and Negative Syndrome Scale (PANSS) and Apathy Evaluation Scale (AES). Self-rated insight was assessed using the Insight Scale for Psychosis (ISP), while the interviewer-rated insight was determined by the PANSS item G12 score. The MATRICS Consensus Cognitive Battery (MCCB) and the University of California San Diego Performance-based Skills Assessment (UPSA) were used to assess participants' cognitive and daily living functions. We also performed correlation and linear regression analyses. The MCCB's social cognition domain and several UPSA components-communication, comprehension/planning, household skills, and total score-correlated significantly with interviewer-rated insight. In the linear regression analysis, communication and comprehension/planning domains of UPSA significantly predicted interviewer-rated insight after adjusting for additional variables. This study demonstrated significant correlations between insight and both cognitive and daily living functions in patients with schizophrenia. Social cognition, communication, and comprehension abilities were associated with insight and should be factored in when implementing rehabilitation, including psychoeducation.
- 30 May 2025
- Published by Taylor & Francis in Psychiatry
- Vol. 89 (1) , 69-81
Relationship Between Cognitive and Daily Living Functions and Insight in Patients with Schizophrenia
To investigate the relationships between insight, cognition, and daily living functions in patients with schizophrenia. Fifty-six clinically stable patients with schizophrenia were evaluated for clinical symptoms using the Positive and Negative Syndrome Scale (PANSS) and Apathy Evaluation Scale (AES). Self-rated insight was assessed using the Insight Scale for Psychosis (ISP), while the interviewer-rated insight was determined by the PANSS item G12 score. The MATRICS Consensus Cognitive Battery (MCCB) and the University of California San Diego Performance-based Skills Assessment (UPSA) were used to assess participants' cognitive and daily living functions. We also performed correlation and linear regression analyses. The MCCB's social cognition domain and several UPSA components-communication, comprehension/planning, household skills, and total score-correlated significantly with interviewer-rated insight. In the linear regression analysis, communication and comprehension/planning domains of UPSA significantly predicted interviewer-rated insight after adjusting for additional variables. This study demonstrated significant correlations between insight and both cognitive and daily living functions in patients with schizophrenia. Social cognition, communication, and comprehension abilities were associated with insight and should be factored in when implementing rehabilitation, including psychoeducation.
- Open Access
- 30 April 2023
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 26 (1) , 18-23
Effects of Token Economy Intervention on Hospitalized Patients With Schizophrenia
Objectives: The purpose of this study was to investigate the effect of token economy intervention on the clinical characteristics and global function of patients with schizophrenia.Methods: From June 1, 2022 to September 1, 2022, token economy intervention was conducted for hospitalized patients with schizophrenia in a mental hospital. Assessments were conducted before and after the intervention. Clinical Global Impression-Schizophrenia scale (CGI-SCH), Schizophrenia Quality of Life Scale (SQLS), Insight Scale for Psychosis (ISP), and Apathy Evaluation Scale (AES) were used to evaluate clinical characteristics. World Health Organization Disability Assessment Schedule (WHODAS) was used for global functional assessment.Results: A total of 51 patients were included in the study. Through token economy intervention, depressive (p=0.001), cognitive symptom domain scores (p<0.001) in CGI-SCH, and SQLS score were significantly decreased (p=0.044). In the WHODAS evaluated by the clinician, the scores of self-care (p=0.012), life activities (p=0.006), and participation in society (p=0.040) decreased significantly.Conclusion: It was confirmed that token economy intervention had a positive effect on depressive symptoms, cognitive symptoms, quality of life, self-care function, daily living function, and social participation function in hospitalized patients with schizophrenia.
- 30 April 2023
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 26 (1) , 18-23
Open AccessEffects of Token Economy Intervention on Hospitalized Patients With Schizophrenia
Objectives: The purpose of this study was to investigate the effect of token economy intervention on the clinical characteristics and global function of patients with schizophrenia.Methods: From June 1, 2022 to September 1, 2022, token economy intervention was conducted for hospitalized patients with schizophrenia in a mental hospital. Assessments were conducted before and after the intervention. Clinical Global Impression-Schizophrenia scale (CGI-SCH), Schizophrenia Quality of Life Scale (SQLS), Insight Scale for Psychosis (ISP), and Apathy Evaluation Scale (AES) were used to evaluate clinical characteristics. World Health Organization Disability Assessment Schedule (WHODAS) was used for global functional assessment.Results: A total of 51 patients were included in the study. Through token economy intervention, depressive (p=0.001), cognitive symptom domain scores (p<0.001) in CGI-SCH, and SQLS score were significantly decreased (p=0.044). In the WHODAS evaluated by the clinician, the scores of self-care (p=0.012), life activities (p=0.006), and participation in society (p=0.040) decreased significantly.Conclusion: It was confirmed that token economy intervention had a positive effect on depressive symptoms, cognitive symptoms, quality of life, self-care function, daily living function, and social participation function in hospitalized patients with schizophrenia.
- Open Access
- 30 October 2022
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 25 (2) , 54-61
Clinical Factors Affecting Constipation in Patients with Schizophrenia Taking Clozapine
Objectives: To investigate clinical factors affecting constipation in patients with schizophrenia taking clozapine.Methods: The participants were patients with schizophrenia taking clozapine and tested for the Therapeutic Drug Monitoring from September 1, 2020 to July 1, 2022 at a university hospital. To evaluate the effect of clozapine on constipation, clozapine dosage, clozapine concentration, and norclozapine concentration were investigated. To evaluate effects of drugs other than clozapine on constipation, dosage and type of other drug were investigated. Anticholinergic Drug Scale was used to evaluate anticholinergic action.Results: A total of 56 patients were enrolled in the study. Clozapine daily dose, clozapine concentration, and norclozapine concentration were higher in the constipated patient group. Through logistic regression analysis, it was discovered that the risk of constipation increased as the norclozapine concentration increased, and the results remained similarly even after adjustments of related variables was performed.Conclusion: It was discoverd that among patients taking clozapine, the higher the norclozapine concentration, the higher the probability of constipation. Among patients taking clozapine, patients with high norclozapine concentration may need additional evaluation and management of constipation.
- 30 October 2022
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 25 (2) , 54-61
Open AccessClinical Factors Affecting Constipation in Patients with Schizophrenia Taking Clozapine
Objectives: To investigate clinical factors affecting constipation in patients with schizophrenia taking clozapine.Methods: The participants were patients with schizophrenia taking clozapine and tested for the Therapeutic Drug Monitoring from September 1, 2020 to July 1, 2022 at a university hospital. To evaluate the effect of clozapine on constipation, clozapine dosage, clozapine concentration, and norclozapine concentration were investigated. To evaluate effects of drugs other than clozapine on constipation, dosage and type of other drug were investigated. Anticholinergic Drug Scale was used to evaluate anticholinergic action.Results: A total of 56 patients were enrolled in the study. Clozapine daily dose, clozapine concentration, and norclozapine concentration were higher in the constipated patient group. Through logistic regression analysis, it was discovered that the risk of constipation increased as the norclozapine concentration increased, and the results remained similarly even after adjustments of related variables was performed.Conclusion: It was discoverd that among patients taking clozapine, the higher the norclozapine concentration, the higher the probability of constipation. Among patients taking clozapine, patients with high norclozapine concentration may need additional evaluation and management of constipation.
- Open Access
- 25 November 2020
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 17 (11) , 1143-1148
Association between Dialysis Adequacy and Cognition in Patients with Peritoneal Dialysis
Objective Cognition of peritoneal dialysis patients is influenced by various factors including dialysis adequacy such as fractional urea clearance (Kt/V) and relative overhydration (RelOH). This study aimed to discover the potential contribution of dialysis adequacy to cognitive function in patients undergoing peritoneal dialysis.Methods Fifty-nine patients undergoing peritoneal dialysis were recruited. Demographic information, comorbidities, and clinical lab findings were retrospectively collected, and dialysis adequacy was determined by the Kt/V and RelOH calculation. Cognition and depression were measured with Digit Symbol Substitution Test, Hopkins Verbal Learning Test, Wechsler memory scale (spatial span), Wisconsin Card Sorting Test, and Beck’s depression inventory. Partial correlation test was used to explore the correlation of dialysis adequacy with cognitive function.Results RelOH showed significant correlation with some of the Wisconsin Card Sorting test results. The categories achieved showed negative correlation (r=-0.32, p=0.02) and trials to complete first category showed positive correlation (r=0.31, p=0.02) with RelOH. Other tasks showed no significant correlation with RelOH. Kt/V.Conclusion Our study demonstrates that peritoneal dialysis adequacy, measured by RelOH, seems to be significantly correlated with the occurrence of cognitive impairment. The outcome suggests that RelOH may have the potential to clarify the role of cognitive impairment in peritoneal dialysis patients.
- 25 November 2020
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 17 (11) , 1143-1148
Open AccessAssociation between Dialysis Adequacy and Cognition in Patients with Peritoneal Dialysis
Objective Cognition of peritoneal dialysis patients is influenced by various factors including dialysis adequacy such as fractional urea clearance (Kt/V) and relative overhydration (RelOH). This study aimed to discover the potential contribution of dialysis adequacy to cognitive function in patients undergoing peritoneal dialysis.Methods Fifty-nine patients undergoing peritoneal dialysis were recruited. Demographic information, comorbidities, and clinical lab findings were retrospectively collected, and dialysis adequacy was determined by the Kt/V and RelOH calculation. Cognition and depression were measured with Digit Symbol Substitution Test, Hopkins Verbal Learning Test, Wechsler memory scale (spatial span), Wisconsin Card Sorting Test, and Beck’s depression inventory. Partial correlation test was used to explore the correlation of dialysis adequacy with cognitive function.Results RelOH showed significant correlation with some of the Wisconsin Card Sorting test results. The categories achieved showed negative correlation (r=-0.32, p=0.02) and trials to complete first category showed positive correlation (r=0.31, p=0.02) with RelOH. Other tasks showed no significant correlation with RelOH. Kt/V.Conclusion Our study demonstrates that peritoneal dialysis adequacy, measured by RelOH, seems to be significantly correlated with the occurrence of cognitive impairment. The outcome suggests that RelOH may have the potential to clarify the role of cognitive impairment in peritoneal dialysis patients.
- Open Access
- 15 July 2020
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 17 (7) , 695-701
Correlation between Performance-Based and Interview-Based Cognitive Measurements in Patients with Schizophrenia
Objective The Measurement and Treatment Research to improve Cognition in Schizophrenia Consensus Cognitive Battery (MCCB) is used to measure the cognitive function of patients with schizophrenia. In some situations, interview-based measures such as the Schizophrenia Cognition Rating Scale (SCoRS) may be appropriate. In this study, we analyzed the correlation between performance- and interview-based measurements in patients with schizophrenia.Methods Fifty-six clinically stable patients were recruited. To evaluate cognitive function, we used the MCCB performance-based measure and the SCoRS interview-based measure. Measurements were taken at baseline, and 2 weeks and 3 months later. Spearman correlations were computed between each SCoRS item’s interviewer rating and each MCCB score.Results The correlation between the MCCB overall T score and the SCoRS global score was the strongest (r=-0.52), while the SCoRS total score and the MCCB Speed of Processing score also correlated (r=-0.48). The SCoRS global score showed statistically significant correlations with all seven MCCB domains and the overall T score.Conclusion This study reveals correlations between MCCB domains and SCoRS items. Since we find that interview-based measurements are highly correlated with performance-based measurements, we suggest them as a useful cognitive function evaluation tool that can easily be applied in clinical settings.
- 15 July 2020
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 17 (7) , 695-701
Open AccessCorrelation between Performance-Based and Interview-Based Cognitive Measurements in Patients with Schizophrenia
Objective The Measurement and Treatment Research to improve Cognition in Schizophrenia Consensus Cognitive Battery (MCCB) is used to measure the cognitive function of patients with schizophrenia. In some situations, interview-based measures such as the Schizophrenia Cognition Rating Scale (SCoRS) may be appropriate. In this study, we analyzed the correlation between performance- and interview-based measurements in patients with schizophrenia.Methods Fifty-six clinically stable patients were recruited. To evaluate cognitive function, we used the MCCB performance-based measure and the SCoRS interview-based measure. Measurements were taken at baseline, and 2 weeks and 3 months later. Spearman correlations were computed between each SCoRS item’s interviewer rating and each MCCB score.Results The correlation between the MCCB overall T score and the SCoRS global score was the strongest (r=-0.52), while the SCoRS total score and the MCCB Speed of Processing score also correlated (r=-0.48). The SCoRS global score showed statistically significant correlations with all seven MCCB domains and the overall T score.Conclusion This study reveals correlations between MCCB domains and SCoRS items. Since we find that interview-based measurements are highly correlated with performance-based measurements, we suggest them as a useful cognitive function evaluation tool that can easily be applied in clinical settings.